BIO-TECHNE Corp — Director's Dealing 2015

Jun 9, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2015-06-08

Reporting Person: VERONNEAU MARCEL (SVP - Clinical Controls)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-06-08	Common Stock	F	309	$98.75	Disposed	34604	Direct
2015-06-08	Common Stock	M	385	$79.41	Acquired	34989	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-08	Stock Option	$79.41	M	385	Disposed	2015-07-24	Common Stock (385)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6831	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$62.46	2016-07-23	Common Stock (494)	494	Direct
Stock Option	$66.25	2017-04-29	Common Stock (10000)	10000	Direct
Stock Option	$58.4	2017-07-29	Common Stock (1281)	1281	Direct
Stock Option	$76.15	2018-07-27	Common Stock (20000)	20000	Direct
Stock Option	$76.15	2018-08-27	Common Stock (1129)	1129	Direct
Stock Option	$74.05	2019-07-26	Common Stock (1097)	1097	Direct
Stock Option	$76.02	2020-07-31	Common Stock (15000)	15000	Direct
Stock option	$94.35	2021-08-12	Common Stock (15000)	15000	Direct

Footnotes

F1: Fully exercisable

F2: Vests 5,0000 on each of 6/30/12, 6/30/13, 6/30/14 and 6/30/15

F3: Vests 3,750 on each of 8/1/14, 8/1/15, 8/1/16 and 8/1/17

F4: Vests 3,750 on each of 8/12/15, 8/12/16, 8/12/17 and 8/12/18